HPC Biosciences IPO Details: Price, Dates & Financials

Shares reserved for the market maker in HPC Biosciences IPO: Up to ₹1 Cr. The market maker provides two-way quotes after listing to keep the stock liquid.

Pre-issue shareholding: 11,400,000 shares. Post-issue shareholding: 15,900,000 shares.

HPC Biosciences IPO is a Fresh Capital issue. Issue type: Fixed Price IPO. Face value is ₹10.

The UPI mandate for HPC Biosciences IPO needs to be accepted by 05 Mar 2013. Approve the mandate request in your UPI app before the deadline, otherwise your bid may be rejected.

The Red Herring Prospectus (RHP) of HPC Biosciences IPO is available on the website of the lead manager and the stock exchange (BSE SME) — see the lead manager links on the main page.

The DRHP is the initial offer document filed for regulatory review, while the RHP includes updated disclosures, final issue details, and the price band (when announced). Comparing both documents helps investors identify changes in the HPC Biosciences IPO's financial information, risks, and offer terms before investing in the HPC Biosciences IPO. Reviewing both documents provides a clearer understanding of the HPC Biosciences IPO before making an investment decision.

The DRHP and RHP of the HPC Biosciences IPO disclose potential risks related to the company's business, financial performance, legal matters, and industry conditions. Reviewing these documents helps investors identify potential concerns about the HPC Biosciences IPO, evaluate the HPC Biosciences IPO's risk factors, and make a more informed decision before investing in the HPC Biosciences IPO.